Mirum Pharmaceuticals, Inc. MIRM Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s investing cash flow?
- Mirum Pharmaceuticals, Inc. (MIRM) reported investing cash flow of -$11.57M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s investing cash flow changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s investing cash flow increased by 28.3% year-over-year, from -$16.13M to -$11.57M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s investing cash flow?
- Over 4 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s investing cash flow has grown at a -15.3% compound annual growth rate (CAGR), from $48.55M to -$24.96M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.